Skip to main content
. 2014 Jul 28;2(7):2325967114542580. doi: 10.1177/2325967114542580

Figure 5.

Figure 5.

Effects of time postsurgery and treatment on eSF properties as described in Figure 3. Representative (A) PRG4 Western Blot and (B) agarose gels of eSF with HA MW markers at left. (C-F) CHA for indicated MW ranges for fibrin and F + MSC. n = 10-12. eSF, equine synovial fluid; F, fibrin; HA, hyaluronan; MSC, mesenchymal stem cell; MW, molecular weight; PRG4, proteoglycan-4.